Insider Transactions in Q1 2024 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 25
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-16.32%
|
$112,500
$15.06 P/Share
|
Mar 25
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+14.03%
|
$15,000
$2.73 P/Share
|
Mar 18
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.55%
|
$15,000
$15.18 P/Share
|
Mar 05
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
5,647
-14.32%
|
$79,058
$14.53 P/Share
|
Mar 04
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
15,653
-29.46%
|
$219,142
$14.52 P/Share
|
Mar 04
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
7,945
-12.33%
|
$111,230
$14.52 P/Share
|
Mar 04
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,468
-17.36%
|
$174,552
$14.52 P/Share
|
Mar 04
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,765
-17.24%
|
$52,710
$14.52 P/Share
|
Mar 04
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
18,349
-19.39%
|
$256,886
$14.52 P/Share
|
Mar 04
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
6,108
-13.7%
|
$85,512
$14.52 P/Share
|
Mar 04
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,888
-29.42%
|
$418,432
$14.52 P/Share
|
Mar 04
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
6,780
-19.39%
|
$94,920
$14.52 P/Share
|
Mar 04
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
6,190
-13.57%
|
$86,660
$14.52 P/Share
|
Mar 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,599
-16.9%
|
$64,386
$14.52 P/Share
|
Mar 04
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,866
-3.94%
|
$40,124
$14.52 P/Share
|
Mar 04
2024
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
53,755
-7.61%
|
$752,570
$14.52 P/Share
|
Mar 01
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
29,662
+9.69%
|
-
|
Mar 01
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,314
+5.45%
|
-
|
Mar 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,253
+20.45%
|
-
|
Mar 01
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,093
+7.31%
|
-
|
Mar 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,409
+17.62%
|
-
|
Mar 01
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,558
+11.31%
|
-
|
Mar 01
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,289
+7.63%
|
-
|
Mar 01
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,184
+8.8%
|
-
|
Mar 01
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
20,426
+7.51%
|
-
|
Mar 01
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
475
-1.85%
|
$7,125
$15.06 P/Share
|
Mar 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,469
+20.26%
|
-
|
Mar 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,685
+2.11%
|
-
|
Mar 01
2024
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
105,094
+2.46%
|
-
|
Feb 26
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
404
-1.42%
|
$5,656
$14.5 P/Share
|
Feb 20
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.62%
|
$20,000
$20.64 P/Share
|
Feb 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,128
-21.88%
|
$78,432
$19.18 P/Share
|
Feb 02
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
872
-6.91%
|
$16,568
$19.18 P/Share
|
Feb 02
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
7,882
-12.11%
|
$149,758
$19.18 P/Share
|
Feb 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,523
-10.5%
|
$85,937
$19.18 P/Share
|
Feb 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+35.19%
|
-
|
Feb 01
2024
|
Richard J Napolitano CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+13.8%
|
-
|
Feb 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,198
+23.68%
|
-
|
Feb 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+20.8%
|
-
|
Jan 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-5.32%
|
$19,000
$19.46 P/Share
|
Jan 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
520
-0.79%
|
$10,920
$21.36 P/Share
|
Jan 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,232
+1.84%
|
-
|